Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney Sinclair

Showing results (241-250 of 256) with videos related to

Pageof 26
Sort By:
Skin Appendage Disorders|September 28, 2019
Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter StudySergio Vañó-Galván, David Saceda-Corralo, Ulrike Blume-Peytavi, et al.
JAAD International|August 9, 2021
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and managementMichela Starace, Matilde Iorizzo, Andrea Sechi, et al.
Journal of the American Academy of Dermatology|June 21, 2020
International collaboration and rapid harmonization across dermatologic COVID-19 registriesEsther E Freeman, Devon E McMahon, George J Hruza, et al.
Journal of the American Academy of Dermatology|February 27, 2021
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patientsSergio Vañó-Galván, Rodrigo Pirmez, Angela Hermosa-Gelbard, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Clinics in Dermatology|September 14, 2021
Learning from disease registries during a pandemic: Moving toward an international federation of patient registriesDmitri Wall, Raed Alhusayen, Bernd Arents, et al.
Journal of the American Academy of Dermatology|March 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areataNekma Meah, Dmitri Wall, Katherine York, et al.
JAMA Dermatology|November 20, 2024
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus StatementYagiz Matthew Akiska, Paradi Mirmirani, Ingrid Roseborough, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2025
Trichoteiromania: A multicentre retrospective descriptive and analytical study of 129 casesMarina Ramos Costa, Flavia Oliveira de Xavier de Brito, João Paulo Yamagata, et al.
Pageof 26

Showing results (241-250 of 256) with videos related to

Sort By:
Pageof 26
Skin Appendage Disorders|September 28, 2019
Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter StudySergio Vañó-Galván, David Saceda-Corralo, Ulrike Blume-Peytavi, et al.
JAAD International|August 9, 2021
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and managementMichela Starace, Matilde Iorizzo, Andrea Sechi, et al.
Journal of the American Academy of Dermatology|June 21, 2020
International collaboration and rapid harmonization across dermatologic COVID-19 registriesEsther E Freeman, Devon E McMahon, George J Hruza, et al.
Journal of the American Academy of Dermatology|February 27, 2021
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patientsSergio Vañó-Galván, Rodrigo Pirmez, Angela Hermosa-Gelbard, et al.
Lancet (London, England)|February 6, 2023
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Afsaneh Alavi, et al.
Lancet (London, England)|November 26, 2023
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trialsMarcus Maurer, Luis Felipe Ensina, Ana Maria Gimenez-Arnau, et al.
Clinics in Dermatology|September 14, 2021
Learning from disease registries during a pandemic: Moving toward an international federation of patient registriesDmitri Wall, Raed Alhusayen, Bernd Arents, et al.
Journal of the American Academy of Dermatology|March 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areataNekma Meah, Dmitri Wall, Katherine York, et al.
JAMA Dermatology|November 20, 2024
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus StatementYagiz Matthew Akiska, Paradi Mirmirani, Ingrid Roseborough, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 9, 2025
Trichoteiromania: A multicentre retrospective descriptive and analytical study of 129 casesMarina Ramos Costa, Flavia Oliveira de Xavier de Brito, João Paulo Yamagata, et al.
Pageof 26